- Tytuł:
- Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status.
- Autorzy:
- Temat:
-
ERLOTINIB
CISPLATIN
CHEMORADIOTHERAPY
LUNG cancer
METASTASISTHERAPEUTICS - Źródło:
- Cancer Research & Treatment; Oct2017, Vol. 49 Issue 4, p981-989, 9p
Czasopismo naukowe